Related Experiment Video
Updated: Aug 5, 2026
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
Factors Determining Sirtuin-1 Target Engagement
Petra Neumann-Staubitz1,2, Yannick Burgdorf1,2, Sarah Hofmann1,2
1Department of Chemical Engineering and Biotechnology, Darmstadt University of Applied Sciences, Darmstadt, Germany.
Advanced Biology
|July 25, 2026
Summary
Sirtuin-1 (Sirt1) deacylase activity is regulated by more than its catalytic site. Post-translational modifications, protein interactions, and compartmentalization control its selectivity in vivo, impacting metabolism and aging.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Sirtuin-1 (Sirt1) is a crucial NAD+-dependent deacylase involved in metabolism, stress response, genome stability, and aging.
- While Sirt1's biochemical and structural properties are known, its substrate selectivity in vivo remains poorly understood, contrasting with its in vitro promiscuity.
Purpose of the Study:
- To review the regulatory mechanisms governing Sirt1 substrate selectivity beyond its catalytic site.
- To elucidate how post-translational modifications, protein interactions, and cellular localization contribute to Sirt1 specificity.
Main Methods:
- Literature review of studies on Sirt1 regulation.
- Analysis of evidence regarding post-translational modifications (PTMs) like phosphorylation, acetylation, and glycosylation.
- Examination of protein-protein interactions and spatial compartmentalization, including liquid-liquid phase separation (LLPS).
Main Results:
- PTMs such as phosphorylation at S27/T530 and S682 modulate Sirt1's activity, nuclear translocation, and cofactor interactions.
- Protein interactions with molecules like DBC1 and PACS2 direct Sirt1 to specific substrates and cellular compartments.
- Spatial factors including nucleocytoplasmic shuttling, PML-NB localization, and LLPS contribute to Sirt1's context-specific targeting.
Conclusions:
- Sirt1 substrate selectivity is a complex process governed by a combination of PTMs, protein interactions, subcellular localization, and phase behavior.
- Understanding these regulatory layers provides a framework for developing targeted Sirt1 modulators for metabolic and age-related diseases.
Related Concept Videos
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...